VIMOVO

Страна: Израел

Език: английски

Източник: Ministry of Health

Активна съставка:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Предлага се от:

ASTRA ZENECA ISRAEL LTD

АТС код:

G02CC02

Лекарствена форма:

TABLETS MODIFIED RELEASE

Начин на приложение:

PER OS

Произведено от:

ASTRA ZENECA AB., SWEDEN

Терапевтична група:

NAPROXEN

Терапевтични показания:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Дата Оторизация:

2011-12-01